Location History:
- Germantown, MD (US) (2017)
- Bethesda, MD (US) (2023)
Company Filing History:
3 out of 3,539 
2 out of 547 
2 out of 1,271 
Years Active: 2017-2024
Title: R Benjamin Free: Innovator in Dopamine Receptor Agonists
Introduction
R Benjamin Free is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of pharmacology, particularly in the development of selective dopamine receptor agonists. His work has implications for treating various neurological disorders.
Latest Patents
R Benjamin Free holds 3 patents related to his research. His latest patents include "Selective D3 dopamine receptor agonists and methods of their use," which discloses a compound of Formula I or a pharmaceutically acceptable salt thereof. Another patent, "Selective D dopamine receptor agonists and methods of their use," also discloses a compound of Formula (I) or a pharmaceutically acceptable salt thereof. These disclosures provide methods for treating patients with Parkinson's disease, dyskinesia, neurodegenerative disorders, and other cognitive dysfunctions by administering the compounds.
Career Highlights
Throughout his career, R Benjamin Free has worked with prestigious institutions such as the National Institutes of Health, a component of the US Department of Health & Human Services, and the University of Kansas Medical Center Research Institute. His research has been pivotal in advancing the understanding of dopamine receptor functions and their therapeutic applications.
Collaborations
R Benjamin Free has collaborated with notable colleagues, including Marc Ferrer and Noel Terrence Southall. These collaborations have enriched his research and contributed to the development of innovative treatments.
Conclusion
R Benjamin Free's work in the field of dopamine receptor agonists showcases his commitment to advancing medical science. His patents and collaborations reflect a dedication to improving treatment options for patients with neurological disorders.